Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1

ABSTRACT A dynamic actin cytoskeleton is necessary for viral entry, intracellular migration, and virion release. For HIV-1 infection, during entry, the virus triggers early actin activity by hijacking chemokine coreceptor signaling, which activates a host dependency factor, cofilin, and its kinase, the LIM domain kinase (LIMK). Although knockdown of human LIM domain kinase 1 (LIMK1) with short hairpin RNA (shRNA) inhibits HIV infection, no specific small-molecule inhibitor of LIMK has been available. Here, we describe the design and discovery of novel classes of small-molecule inhibitors of LIMK for inhibiting HIV infection. We identified R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket. R10015 specifically blocks viral DNA synthesis, nuclear migration, and virion release. In addition, R10015 inhibits multiple viruses, including Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex virus 1 (HSV-1), suggesting that LIMK inhibitors could be developed as a new class of broad-spectrum antiviral drugs. IMPORTANCE The actin cytoskeleton is a structure that gives the cell shape and the ability to migrate. Viruses frequently rely on actin dynamics for entry and intracellular migration. In cells, actin dynamics are regulated by kinases, such as the LIM domain kinase (LIMK), which regulates actin activity through phosphorylation of cofilin, an actin-depolymerizing factor. Recent studies have found that LIMK/cofilin are targeted by viruses such as HIV-1 for propelling viral intracellular migration. Although inhibiting LIMK1 expression blocks HIV-1 infection, no highly specific LIMK inhibitor is available. This study describes the design, medicinal synthesis, and discovery of small-molecule LIMK inhibitors for blocking HIV-1 and several other viruses and emphasizes the feasibility of developing LIMK inhibitors as broad-spectrum antiviral drugs.

[1]  Weilin Wu,et al.  Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors. , 2015, Journal of medicinal chemistry.

[2]  Ying Pei,et al.  Cofilin-1 is involved in regulation of actin reorganization during influenza A virus assembly and budding. , 2014, Biochemical and biophysical research communications.

[3]  E. Hunter,et al.  ROCK1 and LIM Kinase Modulate Retrovirus Particle Release and Cell-Cell Transmission Events , 2014, Journal of Virology.

[4]  Jianglin Fan,et al.  Epidermal Growth Factor Receptor-PI3K Signaling Controls Cofilin Activity To Facilitate Herpes Simplex Virus 1 Entry into Neuronal Cells , 2014, mBio.

[5]  Mark Spear,et al.  Novel anti‐HIV therapeutics targeting chemokine receptors and actin regulatory pathways , 2013, Immunological reviews.

[6]  H. Favoreel,et al.  Alphaherpesviral US3 Kinase Induces Cofilin Dephosphorylation To Reorganize the Actin Cytoskeleton , 2013, Journal of Virology.

[7]  J. Baell,et al.  LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice , 2012, Clinical & Experimental Metastasis.

[8]  H. Wolfson,et al.  Computer-Based Identification of a Novel LIMK1/2 Inhibitor that Synergizes with Salirasib to Destabilize the Actin Cytoskeleton , 2012, Oncotarget.

[9]  Yuntao Wu,et al.  The trinity of the cortical actin in the initiation of HIV-1 infection , 2012, Retrovirology.

[10]  Ying Pei,et al.  Cofilin 1-Mediated Biphasic F-Actin Dynamics of Neuronal Cells Affect Herpes Simplex Virus 1 Infection and Replication , 2012, Journal of Virology.

[11]  G. Cole,et al.  PAK in Alzheimer disease, Huntington disease and X-linked mental retardation , 2012, Cellular logistics.

[12]  F. Manetti.  HIV-1 proteins join the family of LIM kinase partners. New roads open up for HIV-1 treatment. , 2012, Drug discovery today.

[13]  Ron Milo,et al.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.

[14]  Dongyang Yu,et al.  Spinoculation Triggers Dynamic Actin and Cofilin Activity That Facilitates HIV-1 Infection of Transformed and Resting CD4 T Cells , 2011, Journal of Virology.

[15]  J. Chu,et al.  Replication of Alphaviruses: A Review on the Entry Process of Alphaviruses into Cells , 2011, Advances in virology.

[16]  S. Lewin,et al.  Early Events of HIV-1 Infection: Can Signaling be the Next Therapeutic Target? , 2011, Journal of Neuroimmune Pharmacology.

[17]  P. Vorster,et al.  LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection* , 2011, The Journal of Biological Chemistry.

[18]  D. Rekosh,et al.  Single-Nucleotide Changes in the HIV Rev-Response Element Mediate Resistance to Compounds That Inhibit Rev Function , 2011, Journal of Virology.

[19]  Dongyang Yu,et al.  Effects of Microtubule Modulators on HIV-1 Infection of Transformed and Resting CD4 T Cells , 2011, Journal of Virology.

[20]  M. Wainberg,et al.  Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef , 2011, Journal of Virology.

[21]  G. Boucher,et al.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton , 2010, Proceedings of the National Academy of Sciences.

[22]  A. Kolokoltsov,et al.  Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes , 2010, PLoS pathogens.

[23]  M. Wainberg,et al.  Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes , 2010, Retrovirology.

[24]  F. Kirchhoff,et al.  Host proteins involved in HIV infection: new therapeutic targets. , 2010, Biochimica et biophysica acta.

[25]  Yuntao Wu,et al.  Chemokine Coreceptor Signaling in HIV-1 Infection and Pathogenesis , 2009, PLoS pathogens.

[26]  Alan G. E. Wilson,et al.  Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. , 2009, Journal of medicinal chemistry.

[27]  Dongyang Yu,et al.  The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells , 2009, PLoS pathogens.

[28]  L. Margolis,et al.  Measurement of Human Immunodeficiency Virus Type 1 Preintegration Transcription by Using Rev-Dependent Rev-CEM Cells Reveals a Sizable Transcribing DNA Population Comparable to That from Proviral Templates , 2009, Journal of Virology.

[29]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[30]  J. Church.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2008, Pediatrics.

[31]  P. Ross-Macdonald,et al.  Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors , 2008, Molecular Cancer Therapeutics.

[32]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[33]  L. Dong,et al.  HIV Envelope-CXCR4 Signaling Activates Cofilin to Overcome Cortical Actin Restriction in Resting CD4 T Cells , 2008, Cell.

[34]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[35]  Yuntao Wu,et al.  Rev-dependent indicator T cell line. , 2007, Current HIV research.

[36]  Yuntao Wu,et al.  Rev-dependent lentiviral expression vector , 2007, Retrovirology.

[37]  L. Volkman,et al.  Dynamic Nuclear Actin Assembly by Arp2/3 Complex and a Baculovirus WASP-Like Protein , 2006, Science.

[38]  Claire Marie Filone,et al.  Development and characterization of a Rift Valley fever virus cell–cell fusion assay using alphavirus replicon vectors , 2006, Virology.

[39]  A. Kolokoltsov,et al.  Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. , 2006, Journal of virological methods.

[40]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[41]  Niels Galjart,et al.  LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  O. Bernard,et al.  A role for LIM kinase in cancer invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[44]  J. Macdonald,et al.  Abnormal Spine Morphology and Enhanced LTP in LIMK-1 Knockout Mice , 2002, Neuron.

[45]  M. Nishita,et al.  Stromal Cell-Derived Factor 1α Activates LIM Kinase 1 and Induces Cofilin Phosphorylation for T-Cell Chemotaxis , 2002, Molecular and Cellular Biology.

[46]  Yuntao Wu,et al.  Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNA , 2001, Science.

[47]  U. Francke,et al.  A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome--deletion region at 7q11.23. , 2000, American journal of human genetics.

[48]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[49]  Giulio Superti-Furga,et al.  Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling , 1999, Nature.

[50]  R. Chaisson,et al.  Natural history of HIV infection in the era of combination antiretroviral therapy. , 1999, AIDS.

[51]  D. C. Edwards,et al.  Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics , 1999, Nature Cell Biology.

[52]  E. Nishida,et al.  Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization , 1998, Nature.

[53]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[54]  C. Morris,et al.  Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. , 1997, Human molecular genetics.

[55]  G. Woloschak,et al.  The effects of vinblastine on the expression of human immunodeficiency virus type 1 long terminal repeat. , 1997, Leukemia research.

[56]  J. Corbeil,et al.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Merzouki,et al.  HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs. , 1995, Cellular and molecular biology.

[58]  D. Hume,et al.  RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-alpha or taxol. , 1995, Journal of inflammation.

[59]  S. Swingler,et al.  Tumor Necrosis Factor α and Interleukin-1β Induce Specific Subunits of NF-κB to Bind the HIV-1 Enhancer: Characterization of Transcription Factors Controlling Human Immunodeficiency Virus Type 1 Gene Expression in Neural Cells , 1994 .

[60]  L. Donehower,et al.  A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. , 1994, AIDS research and human retroviruses.

[61]  S. Swingler,et al.  Tumour necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. , 1994, Biochemical and biophysical research communications.

[62]  M. Emerman,et al.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.

[63]  S. Swingler,et al.  Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. , 1992, AIDS research and human retroviruses.

[64]  M. Nowak.  HIV mutation rate , 1990, Nature.

[65]  M. Siekevitz,et al.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. , 1987, Science.

[66]  Edgar G. Engleman,et al.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane , 1987, Cell.

[67]  H. Hilger,et al.  [Supravalvular aortic stenosis]. , 1961, Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[68]  J. Denie,et al.  Supravalvular Aortic Stenosis , 1958, Circulation.